REFILE-FDA approves Aquestive's ALS treatment
November 22, 2019 at 17:01 PM EST
The U.S. Food and Drug Administration on Friday approved Aquestive Therapeutics' treatment for neurological disorder amyotrophic lateral sclerosis (ALS).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|